Site US10001 — Morristown, New Jersey

Site US10001 is a clinical research site located in Morristown, New Jersey, United States 07960.

Crixeo Health Trust Score: 47/100 (POOR). This profile has not yet been claimed by the site owner.

Site US10001 has participated in 1 clinical trials.

Therapeutic areas: Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma Cancer, Metastatic Gastric Adenocarcinoma Cancer.

Sponsors: Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 47/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US10001?

Site US10001 has a Crixeo Trust Score of 47/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US10001 conducted?

Site US10001 has 1 clinical trials on record. Their work covers Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma Cancer, Metastatic Gastric Adenocarcinoma Cancer.

Is Site US10001 accredited by Crixeo Health?

Site US10001 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US10001?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.